Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the disease. Here, we...
প্রধান লেখক: | Sear, CE, Pieper, P, Amaral, M, Romanelli, MM, Costa-Silva, TA, Haugland, MM, Tate, JA, Lago, JHG, Tempone, AG, Anderson, EA |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
American Chemical Society
2020
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
অনুযায়ী: Amaral, M, অন্যান্য
প্রকাশিত: (2023) -
Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi
অনুযায়ী: Ferreira, D, অন্যান্য
প্রকাশিত: (2019) -
Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design.
অনুযায়ী: de Sousa, FS, অন্যান্য
প্রকাশিত: (2020) -
Synthesis and anti-parasitic activity of dehydrodieugenol B and analogues
অনুযায়ী: Sear, C
প্রকাশিত: (2020) -
Exploring Synthetic Dihydrobenzofuran and Benzofuran Neolignans as Antiprotozoal Agents against <i>Trypanosoma cruzi</i>
অনুযায়ী: Mariana C. Pagotti, অন্যান্য
প্রকাশিত: (2023-02-01)